Please try another search
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Name | Age | Since | Title |
---|---|---|---|
Bronson Crouch | 48 | 2018 | Chairman & CEO |
George Matcham | 68 | 2018 | Independent Non-Employee Director |
Neil W. Gibson | 66 | 2020 | Lead Independent Non-Employee Director |
Richard Kent McGaughy | 50 | 2020 | Independent Non-Employee Director |
Gwendolyn K. Binder | 49 | 2020 | Independent Non-Employee Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review